Decoding Blood Routine and C-Reactive Protein Results – Tabular Version

Blood Routine Blood routine is abbreviated as blood Rt. Rt stands for Routine Test. The history of blood routine testing is relatively short; in 1953, W.H. Coulter invented the world’s first automatic blood cell counter using the principle of electrical impedance. In 1962, the first blood cell counter in China was successfully developed in Shanghai, … Read more

Classification of Myeloid Tumors/Acute Leukemia: A Global Perspective

Published in: Am J Hematol. 2022;97:514–518 Translated by: Ye Xiangjun Since 2001, under the auspices of the World Health Organization (WHO) and its affiliated International Agency for Research on Cancer (IARC), the classification of hematologic tumors has been standardized as part of the WHO classification series commonly referred to as the “WHO Blue Book.” Before … Read more

Guidelines for Diagnosis and Treatment of Primary Myelofibrosis in China (2019 Edition)

Guidelines for Diagnosis and Treatment of Primary Myelofibrosis in China (2019 Edition)

Click the blue text Follow us Primary myelofibrosis (PMF) has made significant progress in diagnosis and treatment in recent years, such as updates to the WHO diagnostic criteria, new clinical trial data for ruxolitinib, and its market approval in China. To provide standardized clinical practice guidance for hematology doctors in China regarding PMF, the Leukemia … Read more

Summary of Common Risk Scores for Myeloproliferative Neoplasms

Summary of Common Risk Scores for Myeloproliferative Neoplasms

Risk stratification is crucial for assessing complications, survival, and guiding treatment in patients with myeloproliferative neoplasms (MPN). This article summarizes internationally recognized scoring systems for risk stratification of MPN patients used in clinical practice. Note: The prognostic scoring systems related to survival mentioned in this article were developed and validated in populations with a median … Read more

ASH Continuing Education | Accelerated Phase of CML at Diagnosis and Transformation

The 65th Annual Meeting of the American Society of Hematology (ASH) will be held in San Diego, USA, from December 9 to 12, 2023. Professor Jiang Qian’s team summarizes the 2023 ASH Continuing Education on Chronic Myeloid Leukemia (CML) to share with everyone. Today, we present the article: Accelerated Phase of Chronic Myeloid Leukemia (CML) … Read more

Introduction to International Consensus Classification of Hematolymphoid Tumors

Introduction to International Consensus Classification of Hematolymphoid Tumors

Many people are confused about what the International Consensus Classification (ICC) of hematolymphoid tumors is. Today, we will briefly introduce it. To introduce the origin of the ICC, it is inevitable to discuss the origin of the 5th edition of the World Health Organization (WHO) classification, and it is also necessary to review how past … Read more

Expert Insights on Treating Pediatric Leukemia

Expert Insights on Treating Pediatric Leukemia

Expert Insights on Treating Pediatric Leukemia On May 10, 1977, a 13-year-old student from Changqing Village, Ling Shi, named Cheng Jizhu, was brought in by his father, gasping for breath. Two months prior, he suddenly experienced high fever and chills, with a temperature of 40°C, and severe nosebleeds that lasted for two days. His stools … Read more

Introduction to Decitabine (DAC)

Introduction to Decitabine (DAC)

Welcome to reprint, please note the source “Jiangcheng ITP Home”🎉🎉🎉 Decitabine (DAC) is commonly known as an anticancer drug, clinically used for the treatment of myelodysplastic syndromes (MDS), acute myeloid leukemia, chronic myelomonocytic leukemia, and other malignant hematological diseases,because it has demethylation and cytotoxic effects, which can induce cell death. However, its “magical” efficacy in … Read more

Summary of Common Chinese-English Abbreviations in Medical Testing

Summary of Common Chinese-English Abbreviations in Medical Testing

Basic Laboratory Testing Chinese Name English Abbreviation Activated Partial Thromboplastin Time APTT Prothrombin Time PT Bleeding Time BT Thrombin Time TT Fibrinogen Degradation Products FDP D-Dimer D-D Antithrombin III AT-III Fibrinogen FIB/Fb/FI Prothrombin FII Tissue Factor/Thromboplastin FIII/TF Labile Factor FV Stable Factor FVIII Ca2+ FIV Protein C System PC System Protein C PC Protein S … Read more